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Abstract 
Vitamin D is an essential immune-modulator with receptors widely distributed throughout the body, and its 
serum levels fluctuate significantly in individuals between winter and summer months.  This study examines the 
association between low vitamin D status and prevalence of COVID-19 cases around the world and proposes a 
relationship with the seasonal character of the human immune system strength rather than to the seasonal infectivity of 
viruses.  Also, this review suggests that the observed geographical disparities in COVID-19 cases are due to differences 
in vitamin D levels.  On the international scale, serum vitamin D levels are reportedly lowest in China, the Middle East, 
and South Europe; these populations also had the largest outbreaks of COVID-19 cases.  In addition to the geographical 
differences in vitamin D status, there are known risk groups (ethnic, age-related, pregnancies).  In contrast, some countries 
including Canada, Finland, and North Europe incorporate increased amounts of vitamin D through fortified foods, vitamin 
D supplements, and sunbathing.  These countries show the lowest morbidity and mortality rates by COVID-19 infection 
and demonstrate that lower ambient temperatures do not contribute to a higher number of COVID-19 cases.  COVID-19 
has spread around the globe almost simultaneously in both warm and cold areas.  Given this information, vitamin D 
measurement should become an essential component of public health monitoring as a biomarker of immunity status.  
Clinical trials should be conducted to confirm this hypothesis.  COVID-19 tests should be performed together with vitamin 
D status tests to verify this proposed relationship. 
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1.  Introduction 
The morbidity and mortality due to 
COVID-19, not only depends on the virus but also 
on the patient’s responses against this infection.  
The immune defenses play a leading role in the 
survival rate of infected patients (Raoult et al., 
2020).  It is well known that vitamin D is an 
important modulator of the immune system 
(Aranow 2011; Arnljots et al., 2019), which would 
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influence the susceptibility to be affected by 
COVID-19.  
Serum vitamin D or 25-hydroxyvitamin D 
(25(OH)D) levels rise with the dermal exposure to 
sunlight and fall during the “dark months” of the 
year (November to March– in the northern 
hemisphere), fluctuating from 30 to 50% in some 
cases (Lips et al., 2019; Grant et al., 2017; Cinar et 
al., 2014).  Vitamin D status depends on its intake 
through the diet or supplements, but most of it (50% 
and 90% of vitamin D in the body) depends on its 
dermal synthesis under the influence of ultraviolet 
radiation.  In addition to sunlight exposure, the 
production of vitamin D in the skin is modulated by 
latitude, skin-covering clothes, the use of sunblock, 
and skin pigmentation.  Sun exposure has altered 
dermal structure throughout evolution, and 
currently 6 skin types are identified (Fitzpatrick 
scale) that synthesize vitamin D at different rates 
(Lips, 2010), where the pale skin is the most 
efficient and the dark skin is the least efficient 
(Grant et al., 2017; Lips, 2010). 
Unlike melatonin, whose synthesis 
uniquely increases in the pineal gland at night, the 
biosynthetic pathways of vitamin D are directly 
related to sunlight exposure (Mocayar Marón et al., 
2020).  The synthesis of epithelial melanin (as 
influenced by melatonin) in the skin, reduces 
vitamin D production (Álvarez-Artime et al., 2020); 
thus melatonin and vitamin D are inversely related.  
Both vitamin D and melatonin have critical 
immunomodulatory effects, with vitamin D 
stimulating the immune system during the day and 
melatonin maintaining its activity during darkness 
(Mead, 2008). 
In addition to its non-enzymatical 
synthesis, vitamin D is enzymatically converted 
into its active form 1,25-(OH)2D mainly in kidneys 
and liver, and also somewhat in other tissues such 
as prostate, placenta, lungs, brain, and immune cells 
(Adams & Hewison, 2012; Zehnder et al., 2001).  
Vitamin D is a steroid hormone with 1,25-(OH)2D 
being the ligand for vitamin D receptors (VDR).  
Cells lacking the VDR are the exception and their 
widespread distribution underlies the potential 
myriad of physiological actions for vitamin D 
(Rosen et al., 2012).  Moreover, vitamin D 
homeostasis is achieved only within a specific 
range; both excessive and insufficient levels being 
equally bad.  This characteristic would explain why 
daily supplementation with physiological doses of 
vitamin D3 usually yields better results than bolus 
charge supplementation (Alshahrani & Aljohani, 
2013). 
An international consensus about the 
definition of vitamin D deficiency and sufficiency 
is still lacking, but the Institute of Medicine defines 
a 25(OH)D concentration of 50 nmol/L (20 ng/mL) 
as the threshold of sufficiency (Ross et al., 2011).  
The same definition has also been adopted by the 
European Food Safety Agency (Lips et al., 2019).  
Nevertheless, vitamin D deficiency, defined as 
serum 25(OH)D levels <50 nmol/L or <20 ng/mL, 
represents a worldwide public health problem that 
affects at least one billion people (Alshahrani & 
Aljohani, 2013).  One of the primary causes of the 
epidemic vitamin D deficiency worldwide is the 
lack of sun exposure (Cinar et al., 2014); as a result, 
this deficiency may increase with confinement of 
people in their homes during any pandemic, 
including the current COVID-19 outbreak.  
Traditional risk groups for vitamin D deficiency 
include pregnant women, children, elderly people 
and dark skin people (Martín Giménez et al., 2020).  
Especially in the Middle-East and Asia, vitamin D 
deficiency in adults is highly prevalent (Van Schoor 
& Lips, 2011).  Furthermore, our group showed that 
there may be a relationship between inflammatory 
processes induced by chronic over-stimulation of 
the renin-angiotensin system (RAS) and the 
worldwide deficiency of vitamin D.  Therefore, low 
vitamin D levels may represent an important risk 
factor for the development of several diseases 
related to RAS over-activation, such as infectious, 
autoimmune, neurodegenerative, and 
cardiovascular diseases, as well as diabetes and 
cancer (Ferder et al., 2013; Giménez et al., 2020).  
Figure 1 shows some of the main causes of vitamin 
D deficiency which could contribute to the 
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Figure 1  Risk factors for 
vitamin D deficiency which could predispose to COVID-19 
 
2.  Vitamin D status around the world and its 
role as an immunomodulatory/antiviral agent in 
respiratory infections 
An analysis of vitamin D status in Europe 
and Middle-East found that vitamin D deficiency 
occurs in <20% of the population from Northern 
Europe, in 30–60% from Western, Southern and 
Eastern Europe and up to 80% from Middle East 
countries.  Moreover, severe deficiency (serum 
25(OH)D <30 nmol/L or 12 ng/mL) is reported in 
12.5% of Europeans (Lips et al., 2019).  
Skeletal consequences of vitamin D 
deficiency include mineralization defects and lower 
bone mineral density, which causes fractures.  
Extra-skeletal consequences include muscle 
weakness, falls, and acute respiratory infections, 
which are the subject of large ongoing clinical trials 
(Lips et al., 2019).  However, older people with hip 
fracture usually die from pulmonary infection rather 
than from the bone fracture (Panula e al., 2011).  An 
extensive systematic review from 2017 carried out 
on a sample of 10,933 participants from 0-95 years, 
reported that vitamin D supplementation reduced 
the risk of acute respiratory tract infection in all 
participants (Martineau et al., 2019), which 
suggests that vitamin D has a key role in mediating 
the immune response to infection (Bikle, 2009).  
Furthermore, many studies demonstrated that the 
highest influenza rates are closely related with 
lowered serum 25(OH)D concentrations.  Thus, 
although the risk of influenza may be affected by 
environmental temperature and especially by 
absolute humidity (which is able to considerably 
modulate the airborne transmission and survival of 
different viruses such as influenza) (Shaman et al., 
2010), 25(OH)D concentrations may be a 
determining factor in the infective process (Grant et 
al., 2017).  Moreover, cell culture experiments 
provide evidence that vitamin D has direct anti-viral 
effects, particularly against enveloped viruses 
(Beard et al., 2011). In this regard, Cannell and 
colleagues (2006) proposed that influenza 
epidemics are usually seasonal, mostly a result of 
seasonal variations in solar ultraviolet B (UVB) 
doses and serum 25(OH)D concentrations.  
Likewise, it was suggested that increasing the mean 
serum 25(OH)D level to 105 nmol/L could reduce 
global mortality rates by 37,000 deaths annually 
(16,1%) (Grant et al., 2010).  Another report 
estimated that doubling serum 25(OH)D 
concentrations at the global population level could 
lower mortality rates by 10–20%, adding about 2 
years to overall adult life expectancy (Grant, 2011). 
To reiterate, scientific evidence shows that 
advanced age is associated with significantly 
reduced dermal synthesis of vitamin D; aging also 
depletes the endogenous production of many other 
hormones, including the immune stimulator 
melatonin, especially in the frail elderly (Scholtens 
et al., 2016).  Vitamin D and melatonin are 
responsible for mitochondrial homeostasis and lack 
of both or one leads to increased oxidative stress, 
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inflammation, and mitochondrial dysfunction, 
which cause the worsening of different pathologies, 
including respiratory diseases (Mocayar Marón et 
al., 2020; Martín Giménez et al., 2020b) such as 
COVID-19.  
 
3.  Seasonal character of the immune system and 
its influence on global mortality rate from 
COVID-19 
World Bank data related to mortality rates in 
Europe from 1960 to 2018 show a significant rise after 
2008, which is in accordance with existing data about 
the vitamin D levels which were lower in 2000s in 
comparison with previous decades.  Recent mortality 
rates have risen by 8-11% in most West and South 




IE&start=2008/).  The available data show that the 
lowest mortality rates were observed during the 
summer months in both 15-64 and 65+ age groups.  
Moreover, almost a 2-fold rise in mortality rates in 65+ 
compared to the 15-64 group was reported (Lips et al., 
2019; Van Schoor & Lips, 2011).  These results may 
be explained by the higher seasonality fluctuations in 
the immune system, and not the seasonal character of 
viruses (viruses are constantly fluctuating throughout 
the year, especially in children) (Barnard & Colón-
Emeric, 2010; Gavigan & McCullers, 2019).  
Coronaviruses have been a well-known cause of colds 
for decades.  Children usually have 6-10 colds per 
year.  Adults generally have 2-4 colds per year on 
average.  Children are also a risk group for vitamin D 
deficiency, which may explain the increased number 
of colds per year in this group.  Although this does not 
produce deaths in children, probably due to the 
adequate internal synthesis of protective molecules 
such as melatonin and the protection conferred by 
thymus (which remains functional to puberty) against 
infections. Children may be a constant reservoir of 
viruses in society (Zisi et al., 2019; Rondanelli et al., 
2018).  
Xie and Zhu (2020) found no evidence 
documenting that case counts of COVID-19 decline 
when the weather becomes warmer if the temperature 
is above 3 °C.  Cases observed in Ecuador confirmed 
that the COVID-19 outbreak can also happen at 30° C.  
These data strongly confirm the non-seasonal 
character of coronavirus.  Also, Iran, with a hot/dry 
climate and mild temperatures in March, was affected 
by a large number of COVID-19 cases.  Casually, Iran, 
as well as Saudi Arabia and Egypt, have some of the 
lowest serum levels of vitamin D in the Middle East 
(Chakhtoura et al., 2018).  Falling European mortality 
rates during summer months could mean that immune 
response is more robust in this season both in 
adolescent and adult population, due to increased 
serum vitamin D levels related to a high sun exposure, 
which starts to drop significantly when day length 
decreases (Spiro & Buttriss, 2014).  The same 
pronounced seasonality in mortality rates has been 
observed in the USA, which could be associated with 
factors that show seasonal variations such as solar 
UVB doses and serum 25-hydroxyvitamin D 
[25(OH)D] concentrations, gene expression, 
environmental temperature and humidity, among 
others.  However, the factors with the most reliable 
support are seasonal variations in solar UVB doses and 
25(OH)D concentrations (Grant et al., 2017), although 
there are other wavelengths of the visible and near-
visible electromagnetic spectrum that also directly 
impact on cellular physiology (Zimmerman & Reiter, 
2019).  Thus, seasonal variations in temperature seem 
to play a minor role in the susceptibility to COVID-19 
(Grant et al., 2017).  Supporting this, the Middle East 
respiratory syndrome (MERS) epidemic appeared in 
September 2012, which cannot be explained by a 
significant drop in environmental temperatures.  Some 
studies show that Middle East vitamin D deficiency 
occurs in 80% of the population (Chakhtoura et al., 
2018).  This low vitamin D status in Saudi Arabia may 
be the main reason why the population became 
vulnerable to acute respiratory infections in September 
rather than in mid-December, when vitamin D levels 
start to drop more meaningfully (3 months after they 
peak) (Chakhtoura et al., 2018; Bassil et al., 2013).  
Another report claimed that cardiovascular disease 
(which contributes to death by COVID-19) rates are 
usually higher in winter than in summer, regardless of 
whether the country is extremely cold, as in 
Kazakhstan (Rosano et al., 2019), or hot as in Kuwait 
(Van Schoor & Lips, 2011).  Therefore, seasonal 
variations in solar UVB doses and/or serum 25(OH)D 
concentrations seem the most likely reasons for causes 
of death by COVID-19 (Grant et al., 2017).  Figure 2 
shows the seasonal character of immune system and 
the level of susceptibility to COVID-19, as a 
consequence of seasonality of vitamin D status.
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Figure 2  Influence of seasonal character of the immune system and vitamin D status on the susceptibility to 
COVID-19 
 
4.  Vitamin D status as a predictor of the 
susceptibility to COVID-19 infection in the 
world population 
The potential antiviral effect of vitamin D 
has recently been suggested by researchers from 
Iran (Teymoori-Rad et al., 2019).  Another research 
group showed that people with a mean monthly 
serum 25(OH)D concentration of >38 ng/mL (>95 
nmol/L) during the fall-winter period had less than 
half the incidence of acute viral respiratory 
infections as reported in those with lower serum 
vitamin D concentrations (Sabetta et al., 2010).  An 
ecological study found that communities exposed to 
higher solar UVB doses -both in summer and in 
winter-, had a significantly lower mortality rate 
during the pandemic influenza of 1918–1919 in the 
USA (Grant & Giovannucci, 2009).  The proposed 
antiviral and immunomodulatory mechanisms of 
vitamin D included the induction of cathelicidin (or 
LL-37) synthesis, an important epithelial 
antimicrobial peptide.  The well-known 
antimicrobial and anti-endotoxin properties of 
cathelicidin would protect against respiratory 
infections and reduce the severity of the 
inflammatory response induced by cytokines 
(Martineau et al., 2019; Beard et al., 2011).  A study 
in South Korea found that a serum 25(OH)D 
concentration >20 ng/mL was associated with an 
adjusted odds ratio for mortality of 0.94 (95% CI, 
0.90–0.99) for those individuals who developed 
community-acquired pneumonia (Kim et al., 2015).  
As previously mentioned, a link between 
vitamin D status and skin coverage/type is also 
known.  Of interest, vitamin D deficiency is 
prevalent in the Middle East, where the use of 
clothes that cover skin and avoid the sunlight may 
explain this deficiency.  Iran is the most profoundly 
affected by COVID-19 among Middle East 
countries.  A poor to moderate vitamin D status is 
also common in Africa, probably caused by the dark 
skin types (Martín Giménez et al., 2020a).  Vitamin 
D status is much better in North America, where 
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vitamin D deficiency is uncommon, but vitamin D 
insufficiency is still usual.  The generally higher 
levels of vitamin D in North America are because in 
Canada, milk is habitually supplemented with 
vitamin D, and the use of vitamin D supplements is 
relatively standard.  This situation may explain the 
low mortality rate due to COVID-19 in this country.  
Moreover, a better vitamin D status in the Nordic 
countries than in the Mediterranean region may also 
be due to the lighter skin of their inhabitants, greater 
sunlight exposure and higher consumption of cod 
liver oil than in Southern Europe, where people stay 
out of the sunshine and naturally have a darker skin 
color (Lips, 2010). 
Furthermore, the higher mortality by 
influenza observed in Italy compared to other 
European countries, may be attributable to the high 
percentage of elderly people in this country (Rosano 
et al., 2019).  The combination of age and low 
vitamin D status in Italy may explain higher 
mortality rates from influenza as well as COVID-
19.  Also, some studies from the USA in 2012 
showed that influenza vaccinations reduced the risk 
of influenza to some extent, but the effect seemed to 
be higher for children than for elderly people.  The 
administration of a three-strain vaccine in the 2010-
2011 influenza season was 69% effective for 
children from 6 months to 8 years, but only 38% 
effective for adults older than 65 years (Treanor et 
al., 2012), which may be related to differences in 
vitamin D status between both age groups.  
Reinforcing the evidence presented in this 
review, several registry-based observational clinical 
It is also noteworthy that the vitamin D status in 
India is weak to moderate, and 40% of the Indian 
population does not have access to clean water and 
soap; despite this, India has not experienced any 
major epidemics thus far.  However, China, where 
vitamin D status is lower than India, had a high 
incidence of COVID-19 (Lips et al., 2019; Van 
Schoor & Lips, 2011).  This may be because, as a 
general rule, Chinese people admire white skin in 
comparison with black skin, and tend to avoid 
sunlight exposure in order to keep their skin clear 
(Dobson, 2007).  Thus, this factor may be a main 
reason why viral pandemics are initiated in China 
more frequently than in other countries. 
Studies from different countries have been 
already examined an association between low 
plasma vitamin D level and increased risk of 
COVID-19 infection (Merzon et al., 2020; D'Avolio 
et al., 2020; Meltzer et al., 2020). 
5.  Conclusion and prospects 
There is a well-established seasonality in 
human mortality rates by COVID-19, which 
indicates the seasonal character of the immune 
system.  This seasonal character depends mainly on 
two immunomodulatory hormones: vitamin D and 
melatonin.  Children up to 15 years of age are well 
protected from the deficiency of vitamin D by 
abundant amounts of melatonin and that do not 
exhibit seasonal fluctuations in their immune 
system.  
Of special interest, China may continue to 
be the cradle of new viruses because of inadequate 
vitamin D status.  The best example of good 
practices is Canada, where, despite its latitude, there 
is low vitamin D deficiency and COVID-19 deaths 
are among the lowest in the Northern hemisphere. 
It is essential to highlight the importance 
of vitamin D and the maintenance of its homeostasis 
in multiple organs (especially lung, brain, immune 
cells) in order to prevent different severe chronic 
diseases as well as acute respiratory infections such 
as COVID-19.  The prevention of vitamin D 
deficiency requires moderate sunlight exposure 
(sunbathing in cold temperatures was used in 
tuberculosis treatments before the antibiotics era), 
consumption of fish, fortification of foods, and the 
use of vitamin D supplements, among others.  Also, 
it may be advisable to introduce active monitoring 
of vitamin D status for public health reasons.  In this 
regard, the normalizing of vitamin D status could be 
useful for treating or preventing this and similar 
affection.  
It is important to test the hypothesis that 
the use of high doses of vitamin D supplementation 
added or not to usual doses of melatonin, may help 
to improve the response against COVID-19, thereby 
reducing pulmonary and cardiovascular 
complications, and finally, decreasing the death rate 
of high-risk populations. 
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